Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

9.2K views

Cited by 6

09:39 min

February 13th, 2018

10.3791/56651-v

February 13th, 2018

9.2K views

This study establishes an experimental model of pure small fiber neuropathy with resiniferatoxin (RTX). A unique dose of RTX (50 µg/kg) is optimal for developing a small fiber neuropathy model that mimics patient characteristics and could help investigate the nociceptive molecular significance underlying neuropathic pain.

Explore More Videos

Small Fiber Neuropathy

Chapters in this video

0:04

Title

0:46

Establishment of Resiniferatoxin (RTX) Neuropathy

1:45

Behavioral Testing: Hot Plate and von Frey Hair

3:55

Skin Biopsy Preparation and Evaluation of IENFs Innervation

6:18

DRG Section Preparation and Evaluation of Injured Small-Diameter Neurons

7:25

Results: Comparing RTX Doses

8:35

Conclusion

Related Videos